Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of Up to 8 Years of Treatment From the Abatacept Clinical Trial Program
Journal of Rheumatology - Canada
doi 10.3899/jrheum.120906
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2013
Authors
Publisher
The Journal of Rheumatology